Should you buy last week’s losers Shire plc (-6%), Essentra plc (-34%) and Royal Bank of Scotland Group plc (-10%)?

Royston Wild considers whether investors should pile into recent fallers Shire plc (LON: SHP), Essentra plc (LON: ESNT) and Royal Bank of Scotland Group plc (LON: RBS).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am considering the investment appeal of three London laggards.

Drugs dynamo

Medical giant Shire (LSE: SHP) saw its share price sink last week, taking it further away from the five-month highs struck at the start of June. I see this as nothing more than mild profit-taking, however, and believe Shire remains an exceptional long-term stock selection.

The company officially completed its $32bn takeover of US-based Baxalta this month, with chief executive Flemming Ornskov noting that “we have made impressive progress on integration planning since announcing the combination, moving much faster than other transactions of similar size.”

Shire expects the tie-up to generate double-digit compound annual revenues growth in the coming years, with the firm predicting sales of $20bn by 2020. And investors should be encouraged by the Dublin-based business having some 50 products in development at the present time.

The City expects earnings at Shire to shoot 84% higher in 2016 alone. And I reckon a subsequent P/E ratio of 14.2 times makes the business a great pick, given its solid long-term potential.

Up in smoke

I am not so convinced by Essentra’s (LSE: ESNT) earnings prospects, however, following the firm’s shocking trading update last week.

The cigarette filter manufacturer said that it is it is “unlikely to achieve” the trading levels it had earlier anticipated for the full year. The company now expects revenues to remain flat in 2016, at around £1.1bn, with adjusted operating profit estimated at £155m-£165m, down from £171.5m in 2015.

Essentra noted that “conditions in Filter Products have deteriorated owing to a more challenging market backdrop, and certain large projects either not being commercialised or being deferred.” The firm added that restructuring problems in its Health & Personal Care Packaging division have also dented performance in the US and UK.

The City expects earnings to edge 1% higher in 2016, resulting in a conventionally low P/E rating of 11.3 times. But I reckon the structural problems facing the wider tobacco industry makes Essentra a risk too far even at current prices.

Barmy bank

I am also less than enthusiastic over the investment prospects of Royal Bank of Scotland (LSE: RBS). And I am not alone in my bearish stance, with market jitters sending the stock to within a whisker of fresh seven-year troughs below 210p per share last week.

The impact of massive divestments has seen revenues sink at the bank, with RBS chalking up a 13% top-line decline during the first quarter alone, to £3.06bn.

And the possibility of a ‘leave’ vote at this month’s European Union referendum will add further pressure to the bank’s top line — chairman Howard Davies said last month that “around 90% of our income will be generated from clients in the UK” once restructuring is completed.

On top of this, RBS also faces the prospect of rising regulatory costs in the years ahead, particularly ahead of a potential 2018 claims deadline for PPI cases.

An anticipated 53% earnings decline leaves the bank dealing on a P/E rating of 12.4 times. I reckon much stronger banking selections can be found at these prices.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended Essentra. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

2 FTSE income stocks investors should consider buying in April

Income stocks are a great way to build wealth. Our writer details two picks she believes investors should consider snapping…

Read more »